tiprankstipranks
Trending News
More News >
Mothercare PLC (GB:MTC)
LSE:MTC

Mothercare (MTC) AI Stock Analysis

Compare
6 Followers

Top Page

GB:MTC

Mothercare

(LSE:MTC)

Select Model
Select Model
Select Model
Neutral 45 (OpenAI - 5.2)
Rating:45Neutral
Price Target:
2.00p
▼(-8.68% Downside)
Action:ReiteratedDate:12/25/25
The score is held down primarily by weak financial health (negative equity, negative operating/free cash flow, and declining revenue) and a bearish technical setup (below major moving averages with negative MACD). The main offset is a very low P/E, which improves the valuation component but does not outweigh the financial and trend risks.
Positive Factors
Specialist maternal and child retail niche
A focused product set targeting pregnancy, infants and young children creates enduring, repeat purchase demand and category expertise. This specialist positioning supports brand recognition, supplier relationships and a defensible customer base that can sustain revenue recovery over months as conditions improve.
Multichannel retail distribution
Having both physical retail and online channels provides structural resilience: it diversifies sales routes, enables gradual shifts to e‑commerce, and preserves market reach across demographics. This channel flexibility helps mitigate localized disruptions and supports longer‑term revenue rebuilding.
Relatively stable gross profit margin
Stable gross margins indicate the company retains product pricing power or consistent sourcing economics despite revenue variability. That margin stability gives management room to address operating leverage and cost control, improving long‑term profit recovery prospects if volumes stabilize.
Negative Factors
Negative shareholders' equity
Negative equity signals an impaired balance sheet and elevated solvency risk. It limits access to traditional financing, raises lender scrutiny, and increases the likelihood of restructuring needs. Over months this constrains investment, working capital flexibility and long‑term strategic options.
Negative operating and free cash flow
Sustained negative operating and free cash flow erode liquidity and force reliance on external funding or asset sales. This reduces the company's ability to fund inventory, capex or marketing needed to restore growth, raising execution risk and weakening financial resilience over the next several months.
Declining revenue trend
Material, persistent revenue declines impair scale and make fixed costs harder to cover, pressuring margins and profitability. Without clear evidence of sustainable demand recovery, continued top‑line contraction increases the risk that cost cuts will be insufficient to restore durable earnings.

Mothercare (MTC) vs. iShares MSCI United Kingdom ETF (EWC)

Mothercare Business Overview & Revenue Model

Company DescriptionMothercare plc, through its subsidiaries, operates as a specialist franchisor of products for mothers-to-be and children under the Mothercare brand. The company provides clothing, footwear, home, and travel products, as well as toys. It operates approximately 700 Mothercare stores and 400 additional stores under the Mothercare brand, as well as websites through a network of franchise partners in 37 countries. The company was founded in 1961 and is headquartered in Hemel Hempstead, the United Kingdom.
How the Company Makes MoneyMothercare generates revenue primarily through the sale of its diverse product range in both physical retail locations and through its e-commerce platform. The company's key revenue streams include direct sales of maternity and baby products, which encompass clothing, accessories, and nursery essentials. In addition, Mothercare may engage in licensing agreements and partnerships with other brands, allowing it to expand its product offerings and reach a broader customer base. Seasonal promotions, loyalty programs, and strategic marketing efforts also contribute to driving sales and enhancing customer retention, ultimately supporting its financial performance.

Mothercare Financial Statement Overview

Summary
Weak overall fundamentals: declining revenue (-19.3% latest year), inconsistent profitability, negative operating and free cash flow, and a highly stressed balance sheet with negative equity indicating elevated solvency risk.
Income Statement
45
Neutral
Mothercare's income statement reveals significant challenges. The company has experienced a notable decline in revenue over the years, with a revenue growth rate of -19.3% in the most recent year. Despite a positive net profit margin of 15% in 2021, the company has struggled with profitability, as evidenced by negative net income in previous years. The gross profit margin has been relatively stable, but the declining revenue and inconsistent profitability are concerning.
Balance Sheet
30
Negative
The balance sheet shows a precarious financial position. The company has negative stockholders' equity, indicating potential solvency issues. The debt-to-equity ratio is not meaningful due to negative equity, but the high level of debt relative to assets suggests financial risk. The equity ratio is also negative, reflecting the company's reliance on debt financing. Overall, the balance sheet indicates financial instability.
Cash Flow
40
Negative
Cash flow analysis shows mixed results. Operating cash flow has been negative in recent periods, and free cash flow has also been negative, indicating cash flow challenges. The free cash flow growth rate is highly volatile, and the operating cash flow to net income ratio is negative, suggesting inefficiencies in converting income to cash. The company needs to improve its cash flow management to ensure sustainability.
BreakdownTTMMar 2025Sep 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue29.50M38.90M56.20M73.10M82.50M85.80M
Gross Profit11.80M14.80M19.60M20.90M27.60M22.50M
EBITDA15.10M16.40M7.50M6.90M15.80M-10.50M
Net Income6.30M6.20M3.30M-100.00K12.10M-21.50M
Balance Sheet
Total Assets26.30M28.70M22.40M30.60M36.80M35.60M
Cash, Cash Equivalents and Short-Term Investments3.00M4.30M5.00M7.10M9.20M6.90M
Total Debt8.80M8.80M19.90M20.00M20.20M20.40M
Total Liabilities36.40M38.10M52.50M32.40M35.30M78.60M
Stockholders Equity-10.10M-9.40M-30.10M-1.80M1.50M-43.00M
Cash Flow
Free Cash Flow-2.60M-1.50M2.50M-800.00K2.70M-4.40M
Operating Cash Flow-2.60M-1.50M4.80M1.50M5.60M-4.00M
Investing Cash Flow15.50M14.80M-2.30M-2.30M-2.90M-400.00K
Financing Cash Flow-12.60M-14.00M-4.50M-1.20M-500.00K5.20M

Mothercare Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price2.19
Price Trends
50DMA
2.08
Negative
100DMA
2.35
Negative
200DMA
2.66
Negative
Market Momentum
MACD
-0.04
Negative
RSI
50.58
Neutral
STOCH
29.77
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:MTC, the sentiment is Neutral. The current price of 2.19 is above the 20-day moving average (MA) of 1.87, above the 50-day MA of 2.08, and below the 200-day MA of 2.66, indicating a neutral trend. The MACD of -0.04 indicates Negative momentum. The RSI at 50.58 is Neutral, neither overbought nor oversold. The STOCH value of 29.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:MTC.

Mothercare Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
£549.51M47.007.52%13.21%-54.35%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
61
Neutral
£25.94M2.8163.08%-1.96%28.69%
60
Neutral
£16.32M-18.59-5.63%-1.65%-454.55%
60
Neutral
£625.44M-3.49-18.75%-20.36%44.33%
56
Neutral
£683.79M15.481.40%3.94%
45
Neutral
£10.98M1.74-30.78%86.44%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:MTC
Mothercare
1.95
-1.45
-42.65%
GB:SOS
Sosandar PLC
7.25
1.75
31.82%
GB:AO
AO World
98.70
2.10
2.17%
GB:THG
THG
34.90
1.60
4.80%
GB:WRKS
TheWorks.co.uk plc
41.50
20.05
93.47%
GB:MOON
Moonpig Group Plc
221.00
10.18
4.83%

Mothercare Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Mothercare Secures High-Cost Refinancing and Extends Pension Deferrals to 2027
Positive
Feb 20, 2026

Mothercare has refinanced its existing debt by replacing an £8m facility with Gordon Brothers through a new special purpose vehicle backed by a consortium of investors, enlarging the facility to £8.46m at signing with scope to rise to £10m and extending maturity to December 2027. The amended facility, which carries a 25% annual coupon split between cash and payment-in-kind interest, remains technically in default and repayable on demand, but directors say the deal improves alignment between secured creditors and shareholders, even as Gordon Brothers is fully repaid and retains its warrants.

The company has also secured an extension to the deferral of annual pension deficit contributions of £3m per year to March 2027, pushing £6m of payments into a new schedule to be agreed by March 2027, with contributions resuming from April 2027 at an agreed affordable level. Chairman Clive Whiley said the combined refinancing and pension deferral ease material uncertainty, bolster liquidity, and provide flexibility to pursue international growth opportunities, underscoring management’s confidence that the strengthened capital structure can support a renewed push in both existing and new territories.

The most recent analyst rating on (GB:MTC) stock is a Sell with a £1.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.

Other
Mothercare Chairman and CFO Boost Stakes with Major Share Purchases
Positive
Dec 23, 2025

Mothercare plc has disclosed significant share purchases by senior leadership, with chairman Clive Whiley increasing his beneficial interest from 8 million to 50 million shares through the acquisition of 42 million shares via the Zodiac Executive Pension Scheme, and chief financial officer Andy Cook acquiring 5 million shares. The transactions, executed on 23 December 2025 at 1.0p per share on the London Stock Exchange, materially raise insider ownership in the company, a move that may be interpreted by investors as a signal of management confidence in Mothercare’s prospects and alignment of executives’ interests with those of shareholders.

The most recent analyst rating on (GB:MTC) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.

Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
Mothercare Tightens Debt and Bets on Reliance and Ebebek to Rebuild Global Scale
Negative
Dec 23, 2025

Mothercare reported a sharp contraction in its interim performance for the 26 weeks to 27 September 2025, with worldwide franchise retail sales down 25% to £90.7 million, turnover nearly halved to £11.6 million and adjusted EBITDA falling to £0.8 million, leading to an adjusted operating loss of £0.5 million. The decline reflects store closures in the Middle East and its planned exit from Boots, but the group has materially reduced net debt to £5.8 million and is positioning itself as a smaller, cash-generative business. Chairman Clive Whiley highlighted significant progress on strategic partnerships, including a South Asian joint venture with Reliance Brands and a 10‑year licensing deal with Turkish specialist Ebebek, both designed to rebuild scale, expand store footprints and open new routes to market. With Reliance targeting rapid expansion and Ebebek bringing substantial buying and distribution power, Mothercare aims to use these alliances, alongside planned refinancing of its facilities, to reignite growth in global retail sales and restore its market presence following years of geopolitical and pandemic-related disruption.

The most recent analyst rating on (GB:MTC) stock is a Hold with a £2.50 price target. To see the full list of analyst forecasts on Mothercare stock, see the GB:MTC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 25, 2025